Document is current
Any future updates will be listed below
-
Authors
Tokuda, Peter J. K.
Demizu, Yusuke https://orcid.org/0000-0002-4465-4300
Wang, Tianyuan
Fukumitsu, Nobuyoshi
Suzuki, Takeshi
Kurihara, Sho
Hiyama, Eiso
Karakawa, Shuhei
Kosaka, Yoshiyuki
Sasaki, Ryohei
Fukumoto, Takumi
Kokubo, Masaki
Soejima, Toshinori
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP20K08107)
- License Information
-
More Information
Article History
Received: 11 May 2024
Accepted: 4 August 2024
First Online: 10 August 2024
Declarations
:
: Ryohei Sasaki received research funding from Alfresa Pharma Corporation; Takumi Fukumoto received patent licensing fees from Alfresa Pharma Corporation and research funding from Alfresa Pharma Corporation, Kanai Juyo Kogyo Co.,Ltd, and Kureha Corporation.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
